Cilostazol Tablet
Product Images NDC 62135-983

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 62135-983). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Cilostazol Tab 100mg 60s Bottle Label)

FDA Label Image

Image Description (Cilostazol Tab 50mg 60s Bottle Label)

FDA Label Image

Image Description (Cilostazol Tab Figure 1)

Image Description (Cilostazol Tab Figure 1)
This is a graph showing Plasma Concentration (ng/mL) of different types of clostazol metabolites over time (hours). The concentrations of Clostazol, 3,4-dihydroclostazol, and trans-hydroxyclostrazol are presented on the y-axis, while the time in hours is on the x-axis. The concentrations of the metabolites decrease over time.*
FDA Label Image

Image Description (Cilostazol Tab Figure 2)

Image Description (Cilostazol Tab Figure 2)
This is information on the percent mean improvement in maximal walking distance after taking placebo, 50mg of Cilostazol twice a day, and 100mg of Cilostazol twice a day. The study lasted for 12 weeks.*
FDA Label Image

Image Description (Cilostazol Tab Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.